Key Takeaways
- License surge drives 23% YoY revenue: INR 361 crores, powered by 52% YoY license growth and a second consecutive quarter of 53% YoY APAC expansion, though annuity growth softened to 14% as the US pivot to larger accounts pruned small-value SaaS relationships.
- The strategy shift is working, unevenly: A deliberate move to larger accounts has lifted per-deal size and sustained ~25% growth for three years, but US deal velocity remains muted at 16-18% growth while traditional markets like Saudi Arabia, India and APAC respond strongly.
- Insurance and government are the next growth vector: Two sizable insurance deals and one government deal closed this quarter; management aims for these two verticals together to reach ~40% of business, from under 20% today, and eventually rival banking in size.
- Annuity softness is called transient: Annuity revenue dipped below 20% growth after 10 quarters, blamed on US small-account pruning and long-tail execution cycles on large deals; management expects recovery in one to three quarters.
- What to watch next quarter: Whether the promised H2 back-ended license deals materialize, whether annuity growth recovers as guided, and whether US insurance and health pipelines convert into new logos and faster momentum.
Revenue Drivers & the Large-Account Pivot
- License-led quarter: License sales grew 52% YoY, a substantial increase, followed by implementation revenues; APAC delivered 53% YoY growth for the second straight quarter on substantial license deals and new logo acquisitions, albeit on a weaker prior-year base.
- Annuity growth decoupled: Annuity revenue grew only 14% YoY, breaking a 10-quarter streak above 20%, because the US shift from smaller to larger accounts led to closing many small-value SaaS accounts, and larger deal wins over the last five quarters carry stretched execution cycles that delay ATS revenue realization.
- The large-account bet: Over the last three years, new logo acquisition and deal count have been flat, but the company grew ~25% consistently because per-deal size increased. Traditional markets responded with much larger deals; the US has inroads in some large accounts but follow-up sales velocity is lower, yielding 16-18% growth there.
- Cross-sell as the compounding engine: One of the most significant growth areas was cross-selling within the existing customer base; 50% of next year's growth target relies on upsell to existing accounts, where accounts that started at INR 1 crore annual revenue have grown to INR 20-25 crores.
- Platform stickiness creates recurring upsell cycles: The NewgenONE/iBPS/OmniDocs platform sits between core banking and other systems; once a customer implements one use case, they naturally add more rather than buying point solutions, creating recurring upsell cycles every 2-3 years.
Virender Jeet: "If you look at 10 years back, we were selling something like around systems of centralization or what we call a BPM or workflow systems. From that we pivoted to lot of systems where we sold about what we call digital onboarding. These days, it's our end-to-end digital retail or trade or service request management or collection systems, so these are examples."
Vertical & Geographic Momentum
| Market / Vertical | Trend | Commentary |
|---|---|---|
| APAC | ▲ Strong | 53% YoY for second consecutive quarter; substantial license deals and new logos on a weaker base; orders in execution over the next 18 months with long-tail revenue. |
| US | ▬ Muted | 17% YoY growth; large-account product fit established but deal velocity is slow; insurance and health pipelines show early signs; management hopeful of new logos in the next two quarters. |
| Middle East | ▲ Strong | Saudi Arabia showing no signs of weakness; working on very large deals, some expected soon. |
| Banking | ▬ Moderating | Momentum in Indian financial services slightly moderated due to high penetration; diversifying into capital finance and trade; larger trade and captive finance deals expected in H2. |
| Insurance | ▲ Building | Two sizable deals closed this quarter (one in Middle East, one in India); pipeline building across India, APAC and US; product lines still being completed but ready for most use cases. |
| Government | ▲ Building | One Middle East government deal closed; initiatives in Singapore, Saudi, Kuwait and India; stronger momentum expected next quarter. |
- Insurance and government ambition: Management aims for these two verticals together to reach around 40% of business, from less than 20% currently, and in the next 3-4 years both together could become equal to the size of banking.
- Banking will remain the largest segment: Whether banking is 75% or 60% of the mix depends on how fast insurance and government scale; the company is diversifying into capital finance and trade solutions within banking.
Deal Wins & Product Momentum
| Deal | Details |
|---|---|
| Large Indian insurer | INR 25 crores for building a system of engagement; part revenue recognized as license, remainder to execute over 18 months. |
| Top US financial institution | Enterprise content management solution, aggregate order value ~USD 1.5 million. |
| Saudi financial leasing company | Loan origination and collection system, order value USD 1.5 million. |
| Indian infrastructure financing firm | INR 16.9 crores order. |
| Singapore financial institution | Contract with a leading APAC financial institution. |
- New logos: 8 added in Q2.
- Product releases: New versions of OmniDocs and OmniXtract (enterprise content management); enhanced video KYC; NewgenONE Marvin APEX version to streamline complex workflows and ensure secure AI integration.
- Islamic finance launch: Islamic retail and SME financing tool launched for the Middle East market.
- Fadata partnership: Strategic partnership continued with the core insurance solution provider, aimed at helping insurers achieve centralized systems and handle complex, content-rich processes.
AI & GenAI: Early-Stage Demand
- AI is central to client conversations: Customer interest in AI and GenAI is strong, with opportunities carrying a strong AI flavor, though they are not yet completely AI-led.
- Regulatory AI funnel building: The company recently tapped into an industry around regulatory frameworks and how GenAI can support them, and is building a strong funnel.
- LumYn go-to-market: The LumYn product is being targeted initially in financial services for cross-selling and upselling, with predominant usage in retail journeys or collections; not currently used on trade.
Virender Jeet: "The customer is demanding that to be at central to all the use cases he's implementing."
Annuity Trajectory & License Mix
- Annuity softness called transient: Management expects the dip to last one to three quarters, arguing the nature of the business keeps compounding annuity irrespective of quarterly fluctuations; some deals are expected to close this quarter and next, which should refill the ATS bucket.
- License-to-revenue ratio as a leading indicator: As long as license share stays healthy at 50-60% per deal, annual annuity keeps growing at a better rate than the overall growth rate; the current license surge should feed future annuity.
- H2 back-ended pattern: The business is slightly back-ended toward Q3 and Q4 for larger license deals, typical for perpetual license software companies; distribution is roughly 42-44% in H1 and the rest in H2, though this skew is slowly reducing as the company grows.
Virender Jeet: "We think it's a transient affair. It may last for one or two or three quarters, but I think we should -- the nature of the business is, it keeps on compounding annuity irrespective of what we do."
Sales Strategy & the USD 50 Crore Aspiration
- New logo acquisition dominates sales effort: 70% of sales effort is on new logo acquisition, 30% on mining, because without new logos the company cannot grow beyond a point.
- US market recovery bet: Management is hopeful that in the next two quarters, with insurance, health and banking kicking in, they should be able to get more new logos and build momentum in the US.
- The USD 50 crore question: Management declined to give a specific date or year for reaching a USD 50 crore revenue milestone, calling it an aspirational plan; aggressive plans are drawn and investments are being made, with an expectation that in the next 3-4 years the company will not be very far from that target.
- Peer comparison deflected: When asked whether US weakness is industry-wide, management said peers operate in a wider, different business and the company is a niche product company solving specific problems, so they are not the right person to answer.
Virender Jeet: "We have drawn aggressive plans for ourselves. We have aligned the strategy for that and we are aggressively investing on that. As the results start unfolding, as the areas start giving us returns, you will see that the revenue mix and we hope that our growth rates start accelerating from even the current growth rates out there, but pinpointing exactly a date and year is something, which is -- it's an aspirational plan."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Annuity growth recovery | ATS bucket growth to return to a healthier rate as deals close and refill the pipeline | One to three quarters |
| H2 license deals | Larger license deals expected, maintaining the typical back-ended pattern | Q3 and Q4 FY25 |
| US momentum | New logos and momentum from insurance, health and banking verticals | Next two quarters |
| Government deal momentum | Stronger momentum on government deals expected | Next quarter |
| Insurance and government mix | Together to reach ~40% of business (from under 20% currently) | No date; 3-4 years to rival banking in size |
| USD 50 crore revenue | Aspirational; aggressive plans drawn, investments underway | Not before 3-4 years; no specific date committed |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | INR 361 crores, +23% YoY |
| Annuity revenue | INR 205 crores, +14% YoY |
| License sales growth | +52% YoY |
| Profit after tax | INR 70 crores, +47% YoY |
| R&D expenses | 9% of revenues |
| Sales and marketing expenses | 22% of revenues |
| Net trade receivables | INR 442 crores as of 30th September 2024 |
| Net DSO | 117 days |
| H1 FY25 revenue | INR 676 crores, +24% YoY |
| Order book growth (H1) | ~20-22% |
| New logos added | 8 |
| Total active clients | 520 to 540, growing by 20-30 clients per year |
| Revenue from government and insurance | Less than 20% of overall business |
| Revenue from Middle East | 37% of business |
| Client retention (recurring business above INR 50 lakh) | 95% to 98% |